OPUS GENETICS INC. -
1.1000
25-十一月-24 16:45:01
15 分钟延时
股票
+0.0900
+8.91%
今日范围
1.0200 - 1.1200
ISIN
N/A
来源
NASDAQ
-
27 6月 2023 08:00:01 条件 Nasdaq GlobeNewswire
-
21 6月 2023 08:00:00 条件 Nasdaq GlobeNewswire
-
Ocuphire Presents APX3330 ZETA-1 Data at Clinical Trials at the Summit (CTS) 2023
12 6月 2023 08:00:01 条件 Nasdaq GlobeNewswire
-
Ocuphire Pharma, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
24 5月 2023 16:05:00 条件 Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Financial Results for First Quarter 2023 and Provides Corporate Update
15 5月 2023 08:00:01 条件 Nasdaq GlobeNewswire
-
Ocuphire Announces APX3330 and Nyxol® Data Presentations at ASCRS 2023 and Eyecelerator
02 5月 2023 08:30:00 条件 Nasdaq GlobeNewswire
-
Ocuphire Provides Corporate Update and Reiterates Previous Guidance on Clinical Programs
25 4月 2023 08:00:01 条件 Nasdaq GlobeNewswire
-
Ocuphire Appoints Rick Rodgers as Interim Chief Executive Officer
21 4月 2023 08:00:00 条件 Nasdaq GlobeNewswire
-
30 3月 2023 08:00:00 条件 Nasdaq GlobeNewswire
-
Ocuphire Announces APX3330 and Nyxol® Data Presentations at ARVO 2023 Annual Meeting
23 3月 2023 08:00:01 条件 Nasdaq GlobeNewswire
-
Ocuphire Announces APX3330 Phase 2 Data Presentations at Retina Meetings
16 2月 2023 08:30:01 条件 Nasdaq GlobeNewswire
-
13 2月 2023 08:00:00 条件 Nasdaq GlobeNewswire
-
25 1月 2023 16:01:00 条件 Nasdaq GlobeNewswire
-
09 1月 2023 07:00:01 条件 Nasdaq GlobeNewswire
-
06 12月 2022 06:00:00 条件 Nasdaq GlobeNewswire
-
Ocuphire to Present at Five Upcoming Investor/Industry Conferences
21 11月 2022 08:00:01 条件 Nasdaq GlobeNewswire
-
07 11月 2022 16:05:00 条件 Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Financial Results for Third Quarter 2022 and Provides Corporate Update
04 11月 2022 16:30:00 条件 Nasdaq GlobeNewswire
-
02 11月 2022 08:09:57 条件 Nasdaq GlobeNewswire
-
24 10月 2022 08:56:52 条件 Nasdaq GlobeNewswire